Long-Acting Injectable Antipsychotics Reduce Hospitalizations Among Individuals With Early-Phase Schizophrenia

Long-acting injectable antipsychotic (LAI) use by individuals with early-phase schizophrenia can significantly delay time to hospitalization. According to a recent study, people with early-phase schizophrenia treated with a monthly LAI for a year or less avoided psychiatric hospitalization for an average of 614 days compared to an average of 531 days until hospitalization for people…